LakeShore Biopharma
2 known investors
Find your way into LakeShore Biopharma
Lakeshore Biopharma (Nasdaq: LSB, formerly Yisheng Biopharma) is a biopharmaceutical company focused on developing, producing, and selling vaccines and immunological products for infectious diseases. Its main marketed product is a lyophilized human rabies vaccine (Vero cell), and it uses a proprietary PIKA immunomodulating technology.
Investors · 2
Competitors · 6
by search overlapBionpharma6 shared keywordsBionpharma researches, develops, and manufactures generic prescription drugs and over-the-counter products, and is one of the largest US suppliers of softgel capsules. It also sells OTC products online through its A+ Health brand on Amazon.
Eli Lilly6 shared keywordsEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.
IQVIA5 shared keywordsIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
Collegium Pharmaceutical5 shared keywordsCollegium Pharmaceutical is a biopharmaceutical company developing a portfolio of medications to treat serious medical conditions. It serves patients living with serious medical conditions and the healthcare professionals caring for them.
Mereo BioPharma Group3 shared keywordsMereo BioPharma is a biopharmaceutical company publicly traded on Nasdaq under the ticker MREO. This page presents its share price data and SEC filings for investors and commercial partners.
Kite Pharma3 shared keywordsKite develops CAR T-cell therapies that engineer a patient's own immune cells to target and destroy cancer cells. The company focuses on cell therapy treatments for cancers such as diffuse large B-cell lymphoma.
Companies competing with LakeShore Biopharma for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does LakeShore Biopharma do?
- Lakeshore Biopharma (Nasdaq: LSB, formerly Yisheng Biopharma) is a biopharmaceutical company focused on developing, producing, and selling vaccines and immunological products for infectious diseases. Its main marketed product is a lyophilized human rabies vaccine (Vero cell), and it uses a proprietary PIKA immunomodulating technology.
- Who are LakeShore Biopharma's investors?
- LakeShore Biopharma's investors include Adjuvant Capital, F-Prime Capital.